· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2021 / N 2 Поддержание физической активности – как помочь пациенту с хронической обструктивной болезнью легких? З.Р. Айсанов, Е.Н. Калманова, О.Ю. Стулова References 1. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005 May;171(9):972-7. 2. Van Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T. Daily physical activity in subjects with newly diagnosed COPD. Thorax 2013 Oct;68(10):962-3. 3. Tudor-Locke C, Washington TL, Hart TL. Expected values for steps/day in special populations. Preventive Medicine 2009 Aug;49(1):3-11. 4. Gouzi F, Préfaut C, Abdellaoui A, Vuillemin A, Molinari N, Ninot G, Caris G, Hayot M. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Archives of Physical Medicine and Rehabilitation 2011 Oct;92(10):1611-7.e2. 5. Vaes AW, Garcia-Aymerich J, Marott JL, Benet M, Groenen MTJ, Schnohr P, Franssen FME, Vestbo J, Wouters EFM, Lange P, Spruit MA. Changes in physical activity and all-cause mortality in COPD. The European Respiratory Journal 2014 Nov;44(5):1199-209. 6. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Reports 1985 Mar-Apr;100(2):126-31. 7. Howley ET. Type of activity: resistance, aerobic and leisure versus occupational physical activity. Medicine & Science in Sports & Exercise 2001 Jun;33(6 Suppl): S364-9; discussion S419-20. 8. Chuchalin AG, Aysanov ZR. Respiratory muscle dysfunction in chronic obstructive pulmonary diseases. Therapeutic Archive 1988;60(8):126-31 (In Russian). 9. Chuchalin AG, Chernyak AV, Chikina SYu, Avdeyev SN, Naumenko ZhK, Neklyudova GV, Aysanov ZR, Kalmanova EN. Functional diagnostics in pulmonology: guidelines. Moscow: Atmosphere; 2009. 192 p. (In Russian). 10. Aisanov Z, Khaltaev N. Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients. Journal of Thoracic Disease 2020 May;12(5):2791-802. 11. Aysanov ZR, Chuchalin AG, Kalmanova EN. Chronic obstructive pulmonary disease and cardiovascular comorbidity. Kardiologiia 2019;59(8S):24-36 (In Russian). 12. Gorelik IL, Kalmanova EN, Aysanov ZR, Chuchalin AG. Functional and structural changes of the heart in chronic obstructive pulmonary disease in combination with coronary heart disease. Pulmonologiya 2010;1:100-5 (In Russian). 13. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006 Mar;129(3):536-44. 14. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012 Aug;142(2):338-46. 15. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011 Aug;140(2):331-42. 16. Esteban C, Arostegui I, Aburto M, Moraza J, Quintana JM, Aizpiri S, Basualdo LV, Capelastegui A. Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease. Respirology (Carlton, Vic.) 2014 Apr;19(3):330-8. 17. Spruit MA, Pitta F, McAuley E, ZuWallack RL, Nici L. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2015 Oct;192(8):924-33. 18. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WDC, Tal-Singer R, Edwards LD, Calverley PMA, Magnussen H, Polkey MI, Wouters EFM. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respiratory Medicine 2012;106:522-30. 19. Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, Hopkinson NS, Polkey MI, van Remoortel H, Troosters T, Kulich K, Karlsson N, Puhan MA, Garcia-Aymerich J; PROactive consortium. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 2014 Aug; 69(8):731-9. 20. Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, Boonen S, Gosselink R, Decramer M, Troosters T, Janssens W. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2014 Jan;189(1):30-8. 21. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI, Vogiatzis I, Clini EM, Toth M, Gimeno-Santos E, Waschki B, Esteban C, Hayot M, Casaburi R, Porszasz J, McAuley E, Singh SJ, Langer D, Wouters EFM, Magnussen H, Spruit MA. An official European Respiratory Society statement on physical activity in COPD. The European Respiratory Journal 2014 Dec;44(6):1521-37. 22. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-Collazo E, Alvarez-Sala R. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. American Journal of Respiratory and Critical Care Medicine 2009 Sep;180(6):506-12. 23. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. The European Respiratory Journal 2014 Dec;44(6):1447-78. 24. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. The European Respiratory Journal 2009 Feb;33(2):262-72. 25. DePew ZS, Garofoli AC, Novotny PJ, Benzo RP. Screening for severe physical inactivity in chronic obstructive pulmonary disease: the value of simple measures and the validation of two physical activity questionnaires. Chronic Respiratory Disease 2013 Feb;10(1):19-27. 26. Hartman JE, Boezen HM, de Greef MH, Ten Hacken NH. Physical and psychosocial factors associated with physical activity in patients with chronic obstructive pulmonary disease. Archives of Physical Medicine and Rehabilitation 2013 Dec;94(12):2396-402.e7. 27. Lee SH, Kim KU, Lee H, Kim YS, Lee MK, Park HK. Factors associated with low-level physical activity in elderly patients with chronic obstructive pulmonary disease. The Korean Journal of Internal Medicine 2018 Jan;33(1):130-7. 28. Dueñas-Espín I, Demeyer H, Gimeno-Santos E, Polkey MI, Hopkinson NS, Rabinovich RA, Dobbels F, Karlsson N, Troosters T, Garcia-Aymerich J. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. International Journal of Chronic Obstructive Pulmonary Disease 2016 Jun;11:1287-95. 29. Katajisto M, Kupiainen H, Rantanen P, Lindqvist A, Kilpeläinen M, Tikkanen H, Laitinen T. Physical inactivity in COPD and increased patient perception of dyspnea. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:743-55. 30. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. The European Respiratory Journal 2004 Jun;23(6):932-46. 31. O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2001 Sep;164(5):770-7. 32. Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnea during exercise in patients with COPD? The European Respiratory Journal 2012 Aug;40(2):322-9. 33. Mendonca CT, Schaeffer MR, Riley P, Jensen D. Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive. Journal of Applied Physiology (Bethesda, Md.: 1985) 2014 Mar;116(5):570-81. 34. Reilly CC, Ward K, Jolley CJ, Lunt AC, Steier J, Elston C, Polkey MI, Rafferty GF, Moxham J. Neural respiratory drive, pulmonary mechanics and breathlessness in patients with cystic fibrosis. Thorax 2011 Mar;66(3):240-6. 35. Calverley PMA. Dynamic hyperinflation: is it worth measuring? Proceedings of the American Thoracic Society 2006 May;3(3):239-44. 36. Velloso M, Stella SG, Cendon S, Silva AC, Jardim JR. Metabolic and ventilatory parameters of four activities of daily living accomplished with arms in COPD patients. Chest 2003 Apr;123(4):1047-53. 37. Aysanov ZR, Kalmanova EN. Bronchial obstruction and hyper-airiness of the lungs in chronic obstructive pulmonary disease. Practical Pulmonology 2016;2:9-19 (In Russian). 38. Marchetti N, Kaplan A. Dyspnea and hyperinflation in chronic obstructive pulmonary disease: impact on physical activity. Cleveland Clinic Journal of Medicine 2018 Feb;85(2 Suppl 1): S3-10. 39. O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Advances in Therapy 2020 Jan;37(1):41-60. 40. Castro AAM, Kümpel C, Rangueri RC, Oliveira MD, Dornelles RA, Brito ER, Seki TM, Porto EF. Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients. Clinics (Sao Paulo, Brazil) 2012;67(4):319-25. 41. Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, Donaire-Gonzalez D, Ferrer J, Rodríguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J; PAC-COPD Study Group. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. The European Respiratory Journal 2018 Sep;52(3):1800079. 42. Rossi A, Aisanov Z, Avdeev S, Di Maria GD, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, Miravitlles M. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respiratory Medicine 2015 Jul;109(7):785-802. 43. Beeh KM, Singh D, Di Scala L, Drollmann A. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:503-13. 44. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, Kesten S, O’Donnell D. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005 Sep;128(3):1168-78. 45. Maltais F, Celli B, Casaburi R, Porszasz J, Jarreta D, Seoane B, Caracta C. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respiratory Medicine 2011 Apr;105(4):580-7. 46. O’Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, Kramer B; INABLE 1 study group. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respiratory Medicine 2011 Jul;105(7):1030-6. 47. Beeh KM, Watz H, Puente-Maestu L, de Teresa L, Jarreta D, Caracta C, Gil EG, Magnussen H. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial. BMC Pulmonary Medicine 2014 Dec;14:209. 48. Watz H, Krippner F, Kirsten A, Magnussen H, Vogelmeier C. Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease – a randomized, multicenter, double-blind, placebo-controlled study. BMC Pulmonary Medicine 2014 Oct;14:158. 49. Watz H, Mailänder C, Baier M, Kirsten A. Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study). BMC Pulmonary Medicine 2016 Jun;16(1):95. 50. Troosters T, Sciurba FC, Decramer M, Siafakas NM, Klioze SS, Sutradhar SC, Weisman IM, Yunis C. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. NPJ Primary Care Respiratory Medicine 2014 May;24:14003. 51. Demeyer H, Louvaris Z, Frei A, Rabinovich RA, de Jong C, Gimeno-Santos E, Loeckx M, Buttery SC, Rubio N, Van der Molen T, Hopkinson NS, Vogiatzis I, Puhan MA, Garcia-Aymerich J, Polkey MI, Troosters T; Mr Papp PROactive study group and the PROactive consortium. Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial. Thorax 2017 May;72(5):415-23. 52. Demeyer H, Burtin C, Hornikx M, Camillo CA, Van Remoortel H, Langer D, Janssens W, Troosters T. The minimal important difference in physical activity in patients with COPD. PLoS One 2016 Apr;11(4):e0154587. 53. Demeyer H, Burtin C, Hornikx M, Camillo CA, Van Remoortel H, Langer D, Janssens W, Troosters T. The minimal important difference in physical activity in patients with COPD. PLoS One 2016 Apr;11(4):e0154587. 54. Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich R, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer W, van der Molen T, Kulich K, Serra I, Basagaña X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. The European Respiratory Journal 2015 Oct;46(4):988-1000.    [ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]